Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Reproducibility and Method Comparison Studies of the Quo-Test™ A1C System and the Quo-Lab A1C Test and CLIA Waiver Study of the Quo-Test™ A1C System

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Quotient Diagnostics Limited
ClinicalTrials.gov Identifier:
NCT01829061
First received: April 1, 2013
Last updated: November 5, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: January 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)